Skip to contentN
Neogenomics Inc
N
NEONeogenomics Inc Q3 2017 · 10-Q
Revenue$59.14M$59.14Mno prior Q3 2016 on file Net Income-$4.26M-$4.26MN/M vs Q3 2016 EPS Diluted-$0.09-$0.09N/M vs Q3 2016 Gross Profit$24,895,000−9.0% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Neogenomics Inc · CIK 1077183 · Engraved from SEC EDGAR
Operating Cash Flowderived$7,436,000−22.7% Free Cash Flowderived$5,133,000−33.5% Margins · derivedGross margin42.1%
Operating margin-3.5%
Net margin-7.2%
ended Sep 30, 2017 · filed Nov 13, 2017 · 44 d after period end